Fear of Progression in Cancer Patients and Survivors
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
Fear of progression (or fear of recurrence) is an appropriate, adequate response to the real threat of cancer. However, elevated levels of fear of progression can become dysfunctional, affecting well-being, quality of life, and social functioning. Research has shown that fear of progression is one of the most frequent distress symptoms of patients with cancer. As a clear consensus concerning clinically relevant states of fear of progression is still lacking, it is difficult to provide a valid estimate of the rate of cancer patients who clearly suffer from fear of progression. Current evidence suggests that probably 50% of cancer survivors experience moderate to severe fear of progression. Furthermore, many patients express unmet needs in dealing with the fear of cancer spreading. These results underscore the need to provide effective psychological treatments for clinical states of fear of progression. Some psychosocial interventions for treating fear of progression have been developed. Our own, targeted intervention study showed that clinical fear of progression can be effectively treated with brief group therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, patients with severe FOP have more unscheduled visits with health providers or more referrals to the emergency department because of being sensitive to normal body sensations.4”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [4]
In the citing paper
“Fear of progression (FOP), fear of cancer deterioration, is a common and appropriate response to cancer, which can be dysfunctional at high levels.4”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [4]
In the citing paper
“Acceptance and Commitment Therapy is a psychotherapy that enhances psychological flexibility through mindfulness, self as context, acceptance, cognitive defusion, commitment, and values.4”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [4]
In the citing paper
“In certain instances, patients with severe FOP may prefer self-examination over medical tests like mammography and ultrasound to avoid anxiety-inducing situations.4,5”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [4]
In the citing paper
“This can be attributed to the fact that FCR or FOP are related to real stimuli such as cancer recurrence or progression, 4 making cognitive challenging difficult for cancer survivors or patients.”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [4]
Citations
Cites
(1970) · Cited by 24,983
Mitchell, A. J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C., & Meader, N. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70002-x · Cited by 2,449
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217
Frontiers of cognitive therapy
Thase, M. E. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(97)00044-3 · Cited by 1,062
What are the unmet supportive care needs of people with cancer? A systematic review
Harrison, J. D., Young, J. M., Price, M. A., Butow, P. N., & Solomon, M. J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-009-0615-5 · Cited by 905
Four-Week Prevalence of Mental Disorders in Patients With Cancer Across Major Tumor Entities
Mehnert, A., Brähler, E., Faller, H., Härter, M., Keller, M., Schulz, H., Wegscheider, K., Weis, J., Boehncke, A., Hund, B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.0086 · Cited by 649
Simard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608
Armes, J., Crowe, M., Colbourne, L., Morgan, H., Murrells, T., Oakley, C., Palmer, N., Ream, E., Young, A., & Richardson, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5151 · Cited by 587
Lebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586
Self-citationSteer, R. A., & Beck, A. T. (1997) · Cited by 586
Cited by
Mutsaers, B., Butow, P., Dinkel, A., Humphris, G., Maheu, C., Ozakinci, G., Prins, J., Sharpe, L., Smith, A. “., Thewes, B., et al. (2020) · Psycho-Oncology · doi:10.1002/pon.5283 · Cited by 133
“wileyonlinelibrary and expected.(3) While FCR can be adaptive,(2-4) when it is experienced at high levels of severity it leads to significant distress, decreased quality of life,(1) and increased health care use.”
BackgroundSelf-citationBan, Y., Li, M., Yu, M., & Wu, H. L. (2021) · Health and Quality of Life Outcomes · doi:10.1186/s12955-021-01816-7 · Cited by 111
Palliative care: needs of advanced breast cancer patients
Cherny, N. I., Paluch–Shimon, S., & Berner-Wygoda, Y. (2018) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s160462 · Cited by 91
Knebel, C., Menzemer, J., Pohlig, F., Herschbach, P., Burgkart, R., Obermeier, A., von Eisenhart‐Rothe, R., & Mühlhofer, H. (2020) · Surgical Infections · doi:10.1089/sur.2019.368 · Cited by 68
“According to Dinkel et al., fear of progression is one of the most frequent causes of distress in patients with cancer and other chronic diseases [42].”
Self-citationYang, Y., Sun, H., Liu, T., Zhang, J., Wang, H., Liang, W., Chen, Y., & Zhang, B. (2018) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2018.09.003 · Cited by 65
Metadata
- Authors
- Dinkel, A., & Herschbach, P.
- Affiliations
- TUM Klinikum (DE)
- Corresponding author
- Dinkel, Andreas
- Venue
- Recent Results in Cancer Research
- Publisher
- Springer International Publishing
- Published
- 2017-09-19
- Volume
- 210
- Pages
- 13-33
- ISSN
- 0080-0015 (ISSN-L)
- 2197-6767
- OpenAlex
- W2755566856
- Cited by
- 114
- References
- 72
- Citations by year
- 2026: 11 · 2025: 19 · 2024: 24 · 2023: 18 · 2022: 15 · 2021: 14 · 2020: 7 · 2019: 4 · 2018: 2
- FWCI
- 9.51
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Recent results in cancer research/Recent Results in Cancer Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of progression, fear of recurrence, cancer patients, cancer survivors, psychological distress, quality of life, unmet needs, psychosocial interventions, group therapy, psychological intervention
- MeSH terms
- Fear, Humans, Neoplasm Recurrence, Local, Neoplasms, Quality of Life, Survivors, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fear of Progression in Cancer Patients and Survivors. https://app.cochat.ai/papers/10.1007/978-3-319-64310-6_2
- The paper
- Dinkel, A., & Herschbach, P. (2018). Fear of Progression in Cancer Patients and Survivors. Recent Results in Cancer Research. https://doi.org/10.1007/978-3-319-64310-6_2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.